Aprea Therapeutics, Inc. (APRE)

NASDAQ: APRE · Real-Time Price · USD

1.675

-0.078 (-4.45%)

At close: Jun 27, 2025, 4:00 PM

1.700

+0.025 (1.49%)

After-hours: Jun 27, 2025, 7:50 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Novel Synthetic Lethality-based Cancer Therapeutics	583.23K

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Sweden	583.23K